ARCHIVES

Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described

This article is from The Cancer Letter archive.

Vol. 05 No. 49 | December 7, 1979

Download PDF Visit The Full Archive

Related Articles

Chabner Cautions Against Downsizing, Consolidation Of NCI Intramural Programs

March 3, 1995

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

RFAs Available.

July 4, 2003

NIH Revitalization Act Authorizes $3 Billion For NCI In FY97

July 5, 1996

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001